Jeil Pharmaceutical Reports Operating Loss of 10.5 Billion KRW Last Year... Turned to Deficit Compared to Previous Year

[Asia Economy Reporter Hyunseok Yoo] Jeil Pharmaceutical announced on the 22nd that it recorded an operating loss of 10.5 billion KRW last year, turning to a deficit compared to the previous year. During the same period, sales increased by 1.4% to 700.7 billion KRW, and a net loss of 15 billion KRW was recorded, also turning to a deficit.

This content was produced with the assistance of AI translation services.